Author: Kalup Alexander
The rise of the contract workforce in cities across the nation, and questions about whether these workers are eligible to access company-sponsored health benefits, has created confusion. It is up to advisers to stay on top of health insurance regulations to protect clients from unexpected compliance-related stress and financial penalties.
The Food and Drug Administration on Monday warned 12 sellers of dietary supplements to stop claiming their products can cure diseases ranging from Alzheimer’s to cancer to diabetes.
Medicare and Medicaid are better than private insurers at keeping spending per-beneficiary low, a finding that has crucial implications for the current health policy debate, according to a new report.
Hospital lobbies are mounting a coordinated effort to dissuade legislators from supporting Medicare for all, a policy health systems argue would cut into profits and ultimately force facilities to shutter.
The American Hospital Association pushed back on the Health Affairs findings in a statement Tuesday afternoon, saying the authors "use limited data to draw broad conclusions." AHA President Tom Nickels noted that the study uses data from employer-sponsored plans and doesn't include Medicare, Medicaid or Blue Cross Blue Shield claims.
While campaigning for governor last year, Gavin Newsom said he wouldn’t be swayed by political donations.
Universal health care in California could cost $17.3 billion a year, under one plan proposed Friday by UC Berkeley health policy researchers.
Assemblyman Michael Sprinkle, D-Sparks, plans to introduce a bill this legislative session that would create a Medicaid buy-in option for all Nevadans, after a similar proposal passed in the state Assembly and Senate but fell at the hands of former Gov. Brian Sandoval in 2017.
It was not the centerpiece, but health was a persistent theme in President Donald Trump’s State of the Union address at the Capitol on Tuesday night.
The Trump administration has made lowering drug prices one of its top priorities, and last week it unveiled a proposal that could vastly rewrite the way drugs are sold in the United States.